Cleared Traditional

K152323 - Disposable Infusion Needle, Safelock Disposable Infusion Needle

K152323 is an FDA 510(k) clearance for Disposable Infusion Needle, manufactured by Jiangyin Caina Technology Co., Ltd.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 119-day FDA review.

K152323 · Jiangyin Caina Technology Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2015
Decision
119d
Days
Class 2
Risk

K152323 is an FDA 510(k) clearance for the Disposable Infusion Needle, Safelock Disposable Infusion Needle. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Jiangyin Caina Technology Co., Ltd. (Jiangyin, CN). The FDA issued a Cleared decision on December 14, 2015 after a review of 119 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Jiangyin Caina Technology Co., Ltd. devices

FDA 510(k) Submission Details - K152323

510(k) Number K152323 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 17, 2015
Decision Date December 14, 2015
Days to Decision 119 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
10d faster than avg
Panel avg: 129d · This submission: 119d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 783
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K152323.
Extension Set
K153293 · B.Braun Medical, Inc. · Apr 2016
Hospira Extension Sets
K151969 · Icu Medical, Inc. · Jan 2016
Solution Administration Sets with 0.2 Micron Filter
K153158 · Baxter Healthcare Corporation · Dec 2015
Safelock Disposable Blood Collection Set, Disposable Blood Collection Set
K151991 · Jiangyin Caina Technology Co., Ltd. · Dec 2015
BD FlowSmart Set, MiniMed Pro-Set
K153257 · Becton, Dickinson and Company · Dec 2015
Q2 Intravenous Adminstration Sets and Extension Sets
K151079 · Quest Medical, Inc. · Sep 2015